In addition to PGD for single gene disorders, we have the ability to perform human leukocyte antigen (HLA)-typing of embryos.
There has been a growing interest in HLA- typing of embryos as it allows parents to conceive a child that is capable of providing histo-compatible stem cells in order to save the life of a sibling with a disease. The stem cells are obtained from umbilical cord blood at the time of birth and then transferred to the affected sibling. This approach has been used to cure children with a variety of forms of inherited anemia and also for children with leukemia.
At our unit we continually strive to extend the services offered to our clients. We will be offering novel technologies in the near future. Information on these services will be sent to your PGD coordinator.